Dr. Reynolds is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3410 Worth St
Ste 300
Dallas, TX 75246Phone+1 214-370-1500Fax+1 214-370-1585
Summary
- Dr. Jana Reynolds is an established Oncologist based in Dallas, TX. She received her medical degree from Texas Tech University Health Sciences Center School of Medicine in 2008 and completed her residencies and fellowships at Texas A&M College of Medicine-Scott and White Medical Center (Temple) and Baylor University Medical Center. Beyond her substantial medical training, Dr. Reynolds makes valuable contributions to her field through her numerous published works in reputable academic journals. These include Transplantation and Cellular Therapy and Haematologica, encompassing topics from long-term cancer survivor outcomes to hematopoietic cell transplantation. She currently serves as an Associate Program Director at Baylor University Medical Center and leads crucial clinical trials focused on improving cancer survivor health post stem cell transplant and exploring treatments for MDS or AML patients.
Education & Training
Baylor University Medical CenterBlood & Marrow Transplant, 2014 - 2015
Texas A&M College of Medicine-Scott and White Medical Center (Temple)Fellowship, Hematology and Medical Oncology, 2012 - 2014- Texas A&M College of Medicine-Scott and White Medical Center (Temple)Residency, Internal Medicine, 2009 - 2012
Texas Tech University Health Sciences Center School of MedicineClass of 2008
Certifications & Licensure
TX State Medical License 2014 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Self-Management Program and Survivorship Care Plan in Improving the Health of Cancer Survivors After Stem Cell Transplant Start of enrollment: 2020 Oct 29
- Phase 1 Study of Shattuck Labs (SL)-172154 in Subjects With MDS or AML Start of enrollment: 2022 Mar 17
Roles: Principal Investigator
Publications & Presentations
PubMed
- 1 citationsPatient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation in Multiple Myeloma.Rajshekhar Chakraborty, Jean Yi, Lisa Rybicki, Jaime Preussler, Abhinav Deol
Transplantation and Cellular Therapy. 2023-06-01 - Health-Related Quality of Life Outcomes in Older Hematopoietic Cell Transplantation Survivors.Sanghee Hong, Jing Zhao, Shu Wang, Han Wang, Ji-Hyun Lee
Transplantation and Cellular Therapy. 2023-03-01 - 4 citationsHealth-Related Quality of Life in Young Adult Survivors of Hematopoietic Cell Transplantation.Seth J Rotz, Jean C Yi, Betty K Hamilton, Wei Wei, Jaime M Preussler
Transplantation and Cellular Therapy. 2022-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
